ID

27736

Description

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00727831

Link

https://clinicaltrials.gov/show/NCT00727831

Keywords

Versions (1)
  1. 11/27/17 11/27/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 27, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chemotherapeutic Agent Toxicity NCT00727831

English

Eligibility Chemotherapeutic Agent Toxicity NCT00727831

1 forms  
Criteria
Description

Criteria

histologically confirmed newly diagnosed primary cns lymphoma (pcnsl)
Description

Primary central nervous system lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0280803
previously untreated disease
Description

Disease untreated

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332155
diffuse large b-cell lymphoma histology
Description

Diffuse Large B-Cell Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0079744
must be clinically eligible to receive standard 3 g/m² methotrexate if outside trial
Description

Methotrexate Dose

Data type

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
no clinically significant effusions or edema
Description

Effusion Absent | Edema Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0013687
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0013604
UMLS CUI [2,2]
C0332197
patient characteristics:
Description

Client Characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
ecog performance status 0-3
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
neutrophils ≥ 1 x 10^9/l
Description

Neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0200633
platelet count ≥ 100 x 10^9/l
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
bilirubin < 1.5 times upper limit of normal
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
glomerular filtration rate (initially measured by edta/isotope method) ≥ 50 ml/min
Description

Glomerular Filtration Rate EDTA Method

Data type

boolean

Alias
UMLS CUI [1,1]
C0017654
UMLS CUI [1,2]
C0013618
UMLS CUI [1,3]
C0025663
not pregnant or nursing
Description

Pregnancy Absent | Breast Feeding Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
negative pregnancy test
Description

Pregnancy test negative

Data type

boolean

Alias
UMLS CUI [1]
C0427780
fertile patients must use effective contraception during and for 6 months after completion of study therapy
Description

Fertility Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
hiv positivity
Description

HIV Seropositivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
dementia or neurological dysfunction not considered to be due to the pcnsl
Description

Dementia | Neurological Dysfunction | Primary central nervous system lymphoma Uninvolved

Data type

boolean

Alias
UMLS CUI [1]
C0497327
UMLS CUI [2]
C1709219
UMLS CUI [3,1]
C0280803
UMLS CUI [3,2]
C0205429
other serious or uncontrolled medical conditions
Description

Medical condition Serious | Medical condition Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205318
prior malignancy, except adequately treated nonmelanoma skin cancer or carcinoma in situ
Description

Cancer Other | Exception Skin carcinoma Treated | Exception Carcinoma in Situ Treated

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007099
UMLS CUI [3,3]
C1522326
prior concurrent therapy:
Description

Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C0087111
no prior cytotoxic chemotherapy
Description

Cytotoxic Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0677881
no concurrent prophylactic antibiotics
Description

Prophylactic antibiotic

Data type

boolean

Alias
UMLS CUI [1]
C0362063
no concurrent co-trimoxazole
Description

co-trimoxazole

Data type

boolean

Alias
UMLS CUI [1]
C0041044
Back to the top of the page

Similar models

Eligibility Chemotherapeutic Agent Toxicity NCT00727831

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Primary central nervous system lymphoma
Item
histologically confirmed newly diagnosed primary cns lymphoma (pcnsl)
boolean
C0280803 (UMLS CUI [1])
Disease untreated
Item
previously untreated disease
boolean
C0012634 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Diffuse Large B-Cell Lymphoma
Item
diffuse large b-cell lymphoma histology
boolean
C0079744 (UMLS CUI [1])
Methotrexate Dose
Item
must be clinically eligible to receive standard 3 g/m² methotrexate if outside trial
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Effusion Absent | Edema Absent
Item
no clinically significant effusions or edema
boolean
C0013687 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0013604 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Item Group
C1512693 (UMLS CUI)
ECOG performance status
Item
ecog performance status 0-3
boolean
C1520224 (UMLS CUI [1])
Neutrophil count
Item
neutrophils ≥ 1 x 10^9/l
boolean
C0200633 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count ≥ 100 x 10^9/l
boolean
C0032181 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 1.5 times upper limit of normal
boolean
C1278039 (UMLS CUI [1])
Glomerular Filtration Rate EDTA Method
Item
glomerular filtration rate (initially measured by edta/isotope method) ≥ 50 ml/min
boolean
C0017654 (UMLS CUI [1,1])
C0013618 (UMLS CUI [1,2])
C0025663 (UMLS CUI [1,3])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception during and for 6 months after completion of study therapy
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
HIV Seropositivity
Item
hiv positivity
boolean
C0019699 (UMLS CUI [1])
Dementia | Neurological Dysfunction | Primary central nervous system lymphoma Uninvolved
Item
dementia or neurological dysfunction not considered to be due to the pcnsl
boolean
C0497327 (UMLS CUI [1])
C1709219 (UMLS CUI [2])
C0280803 (UMLS CUI [3,1])
C0205429 (UMLS CUI [3,2])
Medical condition Serious | Medical condition Uncontrolled
Item
other serious or uncontrolled medical conditions
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Cancer Other | Exception Skin carcinoma Treated | Exception Carcinoma in Situ Treated
Item
prior malignancy, except adequately treated nonmelanoma skin cancer or carcinoma in situ
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0007099 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Cytotoxic Chemotherapy
Item
no prior cytotoxic chemotherapy
boolean
C0677881 (UMLS CUI [1])
Prophylactic antibiotic
Item
no concurrent prophylactic antibiotics
boolean
C0362063 (UMLS CUI [1])
co-trimoxazole
Item
no concurrent co-trimoxazole
boolean
C0041044 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial